Mireille Hilsum, Comment devient-on écrivain? Sartre, Aragon, Perec et Modiano
نویسندگان
چکیده
منابع مشابه
Adler and Sartre: comment.
I was very much interested in the article by Rom and Ansbacher entitled "An Adlerian Case or a Character by Sartre?" (4) not only because of its intrinsic value but also because I had myself analyzed the hero of Sartre's story "Erostratus" (5, pp. 41-58) and others of this author's characters from the angle of Adler's Individual Psychology some I 5 years ago (6, 7). Before quoting from this ana...
متن کاملComment on Yuan Et Al
It has come to our attention that the work of Yuan et al. [1] is being represented as definitive regarding the existence of a particular nonstrange, isoscalar, spin three dibaryon, d * , which we [2] , among others [3, 4, 5, 6, 8] , have proposed exists. We therefore wish to comment on this paper and its relation to ours and those of others. In our work [2] , the d * dibaryon is constructed in ...
متن کاملComment on study by Backman et al
BfArM acknowledges the submission of the manuscript by Backman et al. (2005) concerning the occurrence of breast cancer associated with Mirena use. The manuscript was scheduled for publication in October 2005 and meanwhile has been published (Backman T. et al. Use of the Levonorgestrel-releasing intrauterine system and breast cancer. Obstet and Gynecol 2005;106:813-7). Unfortunately, the study ...
متن کاملComment on Article by Celeux Et Al
The authors point to several problems occurring if DIC = 2D(θ) − D(θ) is applied to missing data models: (i) the focus of the model depends on whether the missing data z are considered as observations or as parameters or integrated out; (ii) the parameter θ may be non-identifiable; (iii) θ can be a poor estimator of θ. They then investigate modifications of DIC mainly based on estimates other t...
متن کاملComment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
In their recent articles, Ferrannini et al. (1) and Mudaliar et al. (2) suggest that increased ketonemia, improving heart function, might explain the positive results of the BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) study. This suggestion perfectly fits with our recently published hypothesis that glucagon could be the key...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Studi Francesi
سال: 2013
ISSN: 0039-2944,2421-5856
DOI: 10.4000/studifrancesi.3227